183 related articles for article (PubMed ID: 20007859)
1. Analytical validation of protein-based multiplex assays: a workshop report by the NCI-FDA interagency oncology task force on molecular diagnostics.
Rodriguez H; Tezak Z; Mesri M; Carr SA; Liebler DC; Fisher SJ; Tempst P; Hiltke T; Kessler LG; Kinsinger CR; Philip R; Ransohoff DF; Skates SJ; Regnier FE; Anderson NL; Mansfield E;
Clin Chem; 2010 Feb; 56(2):237-43. PubMed ID: 20007859
[TBL] [Abstract][Full Text] [Related]
2. Protein-based multiplex assays: mock presubmissions to the US Food and Drug Administration.
Regnier FE; Skates SJ; Mesri M; Rodriguez H; Tezak Z; Kondratovich MV; Alterman MA; Levin JD; Roscoe D; Reilly E; Callaghan J; Kelm K; Brown D; Philip R; Carr SA; Liebler DC; Fisher SJ; Tempst P; Hiltke T; Kessler LG; Kinsinger CR; Ransohoff DF; Mansfield E; Anderson NL
Clin Chem; 2010 Feb; 56(2):165-71. PubMed ID: 20007858
[TBL] [Abstract][Full Text] [Related]
3. 1st NCI annual meeting on Clinical Proteomic Technologies for Cancer.
Tao F
Expert Rev Proteomics; 2008 Feb; 5(1):17-20. PubMed ID: 18282119
[TBL] [Abstract][Full Text] [Related]
4. Restructuring proteomics through verification.
Boja E; Rivers R; Kinsinger C; Mesri M; Hiltke T; Rahbar A; Rodriguez H
Biomark Med; 2010 Dec; 4(6):799-803. PubMed ID: 21133699
[TBL] [Abstract][Full Text] [Related]
5. Analytical validation considerations of multiplex mass-spectrometry-based proteomic platforms for measuring protein biomarkers.
Boja ES; Fehniger TE; Baker MS; Marko-Varga G; Rodriguez H
J Proteome Res; 2014 Dec; 13(12):5325-32. PubMed ID: 25171765
[TBL] [Abstract][Full Text] [Related]
6. Standards for plasma and serum proteomics in early cancer detection: a needs assessment report from the national institute of standards and technology--National Cancer Institute Standards, Methods, Assays, Reagents and Technologies Workshop, August 18-19, 2005.
Barker PE; Wagner PD; Stein SE; Bunk DM; Srivastava S; Omenn GS
Clin Chem; 2006 Sep; 52(9):1669-74. PubMed ID: 16840585
[TBL] [Abstract][Full Text] [Related]
7. The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers.
Zhang Z; Chan DW
Cancer Epidemiol Biomarkers Prev; 2010 Dec; 19(12):2995-9. PubMed ID: 20962299
[TBL] [Abstract][Full Text] [Related]
8. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
Tahara H; Sato M; Thurin M; Wang E; Butterfield LH; Disis ML; Fox BA; Lee PP; Khleif SN; Wigginton JM; Ambs S; Akutsu Y; Chaussabel D; Doki Y; Eremin O; Fridman WH; Hirohashi Y; Imai K; Jacobson J; Jinushi M; Kanamoto A; Kashani-Sabet M; Kato K; Kawakami Y; Kirkwood JM; Kleen TO; Lehmann PV; Liotta L; Lotze MT; Maio M; Malyguine A; Masucci G; Matsubara H; Mayrand-Chung S; Nakamura K; Nishikawa H; Palucka AK; Petricoin EF; Pos Z; Ribas A; Rivoltini L; Sato N; Shiku H; Slingluff CL; Streicher H; Stroncek DF; Takeuchi H; Toyota M; Wada H; Wu X; Wulfkuhle J; Yaguchi T; Zeskind B; Zhao Y; Zocca MB; Marincola FM
J Transl Med; 2009 Jun; 7():45. PubMed ID: 19534815
[TBL] [Abstract][Full Text] [Related]
9. Regulatory perspective on translating proteomic biomarkers to clinical diagnostics.
Li J; Kelm KB; Tezak Z
J Proteomics; 2011 Nov; 74(12):2682-90. PubMed ID: 21856459
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry based proteomics profiling as diagnostic tool in oncology: current status and future perspective.
Findeisen P; Neumaier M
Clin Chem Lab Med; 2009; 47(6):666-84. PubMed ID: 19445650
[TBL] [Abstract][Full Text] [Related]
11. Cancer Proteomics and the Elusive Diagnostic Biomarkers.
Bradshaw RA; Hondermarck H; Rodriguez H
Proteomics; 2019 Nov; 19(21-22):e1800445. PubMed ID: 31172665
[TBL] [Abstract][Full Text] [Related]
12. The path to clinical proteomics research: integration of proteomics, genomics, clinical laboratory and regulatory science.
Boja ES; Rodriguez H
Korean J Lab Med; 2011 Apr; 31(2):61-71. PubMed ID: 21474978
[TBL] [Abstract][Full Text] [Related]
13. Executive Summary of the National Cancer Institute Workshop: Highlights and recommendations.
Lieberman R; Nelson WG; Sakr WA; Meyskens FL; Klein EA; Wilding G; Partin AW; Lee JJ; Lippman SM
Urology; 2001 Apr; 57(4 Suppl 1):4-27. PubMed ID: 11295590
[TBL] [Abstract][Full Text] [Related]
14. Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers.
Butterfield LH; Palucka AK; Britten CM; Dhodapkar MV; Håkansson L; Janetzki S; Kawakami Y; Kleen TO; Lee PP; Maccalli C; Maecker HT; Maino VC; Maio M; Malyguine A; Masucci G; Pawelec G; Potter DM; Rivoltini L; Salazar LG; Schendel DJ; Slingluff CL; Song W; Stroncek DF; Tahara H; Thurin M; Trinchieri G; van Der Burg SH; Whiteside TL; Wigginton JM; Marincola F; Khleif S; Fox BA; Disis ML
Clin Cancer Res; 2011 May; 17(10):3064-76. PubMed ID: 21558394
[TBL] [Abstract][Full Text] [Related]
15. Proteomic approaches to cancer biomarkers.
Hung KE; Yu KH
Gastroenterology; 2010 Jan; 138(1):46-51.e1. PubMed ID: 19931265
[No Abstract] [Full Text] [Related]
16. Reconstructing the pipeline by introducing multiplexed multiple reaction monitoring mass spectrometry for cancer biomarker verification: an NCI-CPTC initiative perspective.
Rodriguez H; Rivers R; Kinsinger C; Mesri M; Hiltke T; Rahbar A; Boja E
Proteomics Clin Appl; 2010 Dec; 4(12):904-14. PubMed ID: 21137031
[TBL] [Abstract][Full Text] [Related]
17. Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles).
Kinsinger CR; Apffel J; Baker M; Bian X; Borchers CH; Bradshaw R; Brusniak MY; Chan DW; Deutsch EW; Domon B; Gorman J; Grimm R; Hancock W; Hermjakob H; Horn D; Hunter C; Kolar P; Kraus HJ; Langen H; Linding R; Moritz RL; Omenn GS; Orlando R; Pandey A; Ping P; Rahbar A; Rivers R; Seymour SL; Simpson RJ; Slotta D; Smith RD; Stein SE; Tabb DL; Tagle D; Yates JR; Rodriguez H
Proteomics; 2012 Jan; 12(1):11-20. PubMed ID: 22069307
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for mass spectrometry data quality metrics for open access data (corollary to the Amsterdam principles).
Kinsinger CR; Apffel J; Baker M; Bian X; Borchers CH; Bradshaw R; Brusniak MY; Chan DW; Deutsch EW; Domon B; Gorman J; Grimm R; Hancock W; Hermjakob H; Horn D; Hunter C; Kolar P; Kraus HJ; Langen H; Linding R; Moritz RL; Omenn GS; Orlando R; Pandey A; Ping P; Rahbar A; Rivers R; Seymour SL; Simpson RJ; Slotta D; Smith RD; Stein SE; Tabb DL; Tagle D; Yates JR; Rodriguez H
Proteomics Clin Appl; 2011 Dec; 5(11-12):580-9. PubMed ID: 22213554
[TBL] [Abstract][Full Text] [Related]
19. Committee on Natural Toxins and Food Allergens. Marine and freshwater toxins.
Hungerford JM
J AOAC Int; 2005; 88(1):299-313. PubMed ID: 15759755
[TBL] [Abstract][Full Text] [Related]
20. Standards in molecular diagnostics for the discovery and validation of clinically useful cancer biomarkers.
Vydelingum NA; Sorbara L; Wagner P; Srivastava S
Expert Rev Mol Diagn; 2013 Jun; 13(5):421-3. PubMed ID: 23782249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
